ArticleJournal of theoretical biology2021
Transmission dynamics of COVID-19 in Nepal: Mathematical model uncovering effective controls.
Article in Journal of theoretical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A cross-sectional quantitative analysis of production and requirements of medical oxygen during the COVID-19 pandemic in Nepal.BMJ open · 2025Article
- Modeling measles transmission in adults and children: Implications to vaccination for eradication.Infectious Disease Modelling · 2024Article
- Article
- Mathematical modeling to study the impact of immigration on the dynamics of the COVID-19 pandemic: A case study for Venezuela.Spatial and spatio-temporal epidemiology · 2022Article
- How optimal allocation of limited testing capacity changes epidemic dynamics.Journal of theoretical biology · 2022Article
- Inter-provincial disparity of COVID-19 transmission and control in Nepal.Scientific reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While most of the countries around the globe are combating the pandemic of COVID-19, the level of its impact is quite variable among different countries. In particular, the data from Nepal, a developing country having an open border provision with highly COVID-19 affected country India, has shown a biphasic pattern of epidemic, a controlled phase (until July 21, 2020) followed by an outgrown phase (after July 21, 2020). To uncover the effective strategies implemented during the controlled phase, we develop a mathematical model that is able to describe the data from both phases of COVID-19 dynamics in Nepal. Using our best parameter estimates with 95% confidence interval, we found that during the controlled phase most of the recorded cases were imported from outside the country with a small number generated from the local transmission, consistent with the data. Our model predicts that these successful strategies were able to maintain the reproduction number at around 0.21 during the controlled phase, preventing 442,640 cases of COVID-19 and saving more than 1,200 lives in Nepal. However, during the outgrown phase, when the strategies such as border screening and quarantine, lockdown, and detection and isolation, were altered, the reproduction number raised to 1.8, resulting in exponentially growing cases of COVID-19. We further used our model to predict the long-term dynamics of COVID-19 in Nepal and found that without any interventions the current trend may result in about 18.76 million cases (10.70 million detected and 8.06 million undetected) and 89 thousand deaths in Nepal by the end of 2021. Finally, using our predictive model, we evaluated the effects of various control strategies on the long-term outcome of this epidemics and identified ideal strategies to curb the epidemic in Nepal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.